Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Repligen Corp (RGEN) -- Ignore unavailable to you. Want to Upgrade?

To: Harvey Allen who wrote (367)	12/26/2007 1:03:48 PM
From: Bob Laz	Read Replies (1) \| Respond to of 395

Harvey - The Biotech Insight / Dr Garren seems to be a very insightful biotech investment tool. Do you currently subscribe - has it helped get you in EARLY - like the idea of $1 - $2 down and $10-$30 up! HA! In any event if you do subscribe maybe we can share the cost - particularly if you feel its a valuable tool. He seems to have been very accurate on RGEN - early on! PS - Quantify000@yahoo.com is my other email for public but somewhat more private if that helps.